Evommune (EVMN) Profit After Tax (2024 - 2026)
Evommune's (EVMN) quarterly Profit After Tax came in at -$21.7 million in Q1 2026, down 48.89% year-on-year from -$42.4 million in Q1 2025, and up 23.34% on a QoQ basis from -$28.3 million in Q4 2025.
Evommune (EVMN) Profit After Tax (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Profit After Tax data on file, last reported at -$21.7 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 48.89% year-over-year to -$21.7 million in Q1 2026; TTM through Mar 2026 was -$77.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$68.9 million, down 3.09% from the prior year.
- Profit After Tax for Q1 2026 stood at -$21.7 million, up from -$28.3 million in the prior quarter.
- Over the last five years, Profit After Tax for EVMN reached as high as -$12.5 million in Q3 2025 and fell as low as -$28.3 million in Q4 2025.
- Historically, Profit After Tax has averaged -$18.9 million across 3 years, with a median of -$18.3 million in 2024.
- Across the five-year window, Profit After Tax increased 21.62% in 2025 and slumped 48.89% in 2026, its largest moves.
- Year by year, Profit After Tax stood at -$20.7 million in 2024, then slumped by 36.41% to -$28.3 million in 2025, then rose by 23.34% to -$21.7 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$21.7 million in Q1 2026, -$28.3 million in Q4 2025, and -$12.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Evommune | 381.48 Mn | 170.02 Mn | - | -21.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.67 Mn |
| Dec 31, 2025 | -28.27 Mn |
| Sep 30, 2025 | -12.48 Mn |
| Mar 31, 2025 | -14.56 Mn |
| Dec 31, 2024 | -20.73 Mn |
| Sep 30, 2024 | -15.92 Mn |